Early real-world outcomes in patients with neovascular Age-related Macular Degeneration (nAMD) treated with Faricimab

被引:0
|
作者
Raslan, Walid [1 ]
Younis, Saad [1 ]
Fabozzi, Lorenzo [2 ]
Hassan, Islam [1 ]
Palmieri, Filomena [1 ]
机构
[1] Western Eye Hosp London, London, England
[2] Moorfields Eye Hosp NHS Fdn Trust London, London, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study
    Grimaldi, Gabriela
    Cancian, Giuseppe
    Rizzato, Angelica
    Casanova, Alex
    Perruchoud-Ader, Kathrin
    Clerici, Michele
    Consigli, Andrea
    Menghini, Moreno
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (04) : 1151 - 1159
  • [22] Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
    Yi-Sheng Chang
    Wan-Ju Lee
    Chen-Chee Lim
    Shih-Hao Wang
    Sheng-Min Hsu
    Yi-Chian Chen
    Chia-Yi Cheng
    Yu-Ti Teng
    Yi-Hsun Huang
    Chun-Chieh Lai
    Sung-Huei Tseng
    [J]. Scientific Reports, 8
  • [23] Real-world evidence for neovascular age-related macular degeneration: a practical approach
    Teo, Kelvin Yi Chong
    [J]. EYE, 2023, 37 (01) : 1 - 3
  • [24] Real-world evidence for neovascular age-related macular degeneration: a practical approach
    Kelvin Yi Chong Teo
    [J]. Eye, 2023, 37 : 1 - 3
  • [25] Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
    Chang, Yi-Sheng
    Lee, Wan-Ju
    Lim, Chen-Chee
    Wang, Shih-Hao
    Hsu, Sheng-Min
    Chen, Yi-Chian
    Cheng, Chia-Yi
    Teng, Yu-Ti
    Huang, Yi-Hsun
    Lai, Chun-Chieh
    Tseng, Sung-Huei
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [26] Two Year Real World Outcomes of Ranibizumab Therapy for Neovascular Age Related Macular Degeneration (nAMD)
    Bhalla, Minak
    Muniraju, Ramu
    [J]. OPHTHALMOLOGICA, 2014, 232 : 4 - 4
  • [27] Predicting visual outcomes in patients treated with aflibercept for neovascular age-related macular degeneration: Data from a real-world clinical setting
    Fulcher, Corinne
    Hazel, Charlotte A.
    Pacey, Ian
    Ali, Hasan
    Ghanchi, Faruque D.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (03) : 543 - 549
  • [28] The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study-6 month results
    Khanani, Arshad M.
    Aziz, Aamir A.
    Khan, Hannah
    Gupta, Ashwin
    Mojumder, Ohidul
    Saulebayeva, Aigerim
    Abbey, Ashkan M.
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark R.
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara J.
    London, Nikolas J. S.
    Mein, Luke
    Sheth, Veeral S.
    Wolfe, Jeremy D.
    Singer, Michael A.
    Danzig, Carl J.
    [J]. EYE, 2023, 37 (17) : 3574 - 3581
  • [29] ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD)
    Liakopoulos, Sandra
    Spital, Georg
    Brinkmann, Christian K.
    Schick, Tina
    Ziemssen, Focke
    Voegeler, Jessica
    Koch, Mirja
    Kirchhof, Bernd
    Holz, Frank G.
    Pauleikhoff, Daniel
    Schmitz-Valckenberg, Steffen
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2020, 104 (11) : 1573 - 1578
  • [30] Changes in Quality of Life Among Patients Treated with Aflibercept for neovascular Age-related Macular Degeneration (nAMD)
    Wijeyakumar, Wijeyanthy
    Hong, Thomas
    Broadhead, Geoffrey
    Li, Haitao
    Zhu, Meidong
    Chang, Andrew Alexander
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)